Drug-tolerant persister (DTP) cells are a rare subpopulation of cancer cells that can survive chemotherapy through reversible non-genetic mechanisms. Here, the authors provide their perspective on the existing gaps and outline the research paths still required to bridge basic DTP research with effective clinical strategies.
- Zhile Wang
- Mengyao Wang
- Shensi Shen
